Platelet factor 4: production, structure, and physiologic and immunologic action.
about
Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cellsImmune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion.Platelet factor-4 is an indicator of blood count recovery in acute myeloid leukemia patients in complete remission.PF4/heparin complexes are T cell-dependent antigens.Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia.Low-density lipoprotein apheresis reduces platelet factor 4 on the surface of platelets: a possible protective mechanism against heparin-induced thrombocytopenia and thrombosis.PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI.Activated platelet-derived and leukocyte-derived circulating microparticles and the risk of thrombosis in heparin-induced thrombocytopenia: A role for pf4-bearing microparticles?The unique immunological features of heparin-induced thrombocytopenia.Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia.Bovine platelets retain functional activity in the presence of penicillin G.Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factorPilot analysis of cytokines levels in stored granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell concentrates.Ginkgolide B reduces atherogenesis and vascular inflammation in ApoE(-/-) micePlatelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum.Megakaryocytic leukemia and platelet factor 4.Enzymatic digestion of the milk protein beta-casein releases potent chemotactic peptide(s) for monocytes and macrophages.Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg.Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology.Platelet alpha-granules: basic biology and clinical correlates.Tumor angiogenesis: insights and innovations.Rat platelets contain glycosylated and non-glycosylated forms of platelet factor 4. Identification and characterization by mass spectrometry.CXCL4 Exposure Potentiates TLR-Driven Polarization of Human Monocyte-Derived Dendritic Cells and Increases Stimulation of T Cells.The antiphospholipid syndrome: from pathophysiology to treatment.Steroids Regulate CXCL4 in the Human Endometrium During Menstruation to Enable Efficient Endometrial Repair.Platelet factor 4 (CXCL4) facilitates human macrophage infection with HIV-1 and potentiates virus replication.Activation of the megakaryocyte-specific gene platelet basic protein (PBP) by the Ets family factor PU.1.Core2 1-6-N-glucosaminyltransferase-I deficiency protects injured arteries from neointima formation in ApoE-deficient mice.Bovine granulocyte chemotactic protein-2 is secreted by the endometrium in response to interferon-tau (IFN-tau).Platelet factor 4 upregulates matrix metalloproteinase-1 production in gingival fibroblasts.Platelet factor 4 release in patients undergoing cardiopulmonary resuscitation--can reperfusion be impaired by platelet activation?Quantitative pattern analysis of the N-terminally processed isoforms of platelet factor-4 in serum.Platelet factor 4 (CXCL4) seals blood clots by altering the structure of fibrin.Glycosaminoglycan Neutralization in Coagulation Control.AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
P2860
Q28378442-9B292015-9B0C-4B87-A17E-2A712D41DF58Q30483035-84CA9428-9E43-46AF-9A56-0E26A524423DQ30838366-CEBF7390-2EA3-4DA7-92B5-FE51AB76DE0BQ33365918-A4572CDD-05ED-4D50-8CF4-65CF07D59163Q33376811-F0763C20-ED12-44BF-BDBA-6BC227FF7E6AQ33392466-4A228C17-1CC7-4174-8D6E-4EFE9DF493CFQ33400120-6CD5E8E8-8369-4D3B-9A8C-7AAF23EE2B38Q33438155-17000838-944B-4929-88FC-E6076C0997F9Q33440626-C75CDE1F-AE06-40DB-BBC8-1F32D93BE1F6Q33502479-23B78A0F-814B-4AEE-905F-A256B980C455Q34094486-C44F90ED-FBD7-4814-9426-3F3C63F9099AQ34235387-13F92056-EE1D-4908-86DC-EAC428576755Q34279813-072D1919-D47C-49F6-9E1E-ED648B333B0CQ34290883-A0B2687D-87AE-4162-A231-F10BD782B367Q34316582-74F7E5B1-98F1-42D4-88E6-8244AA92B7FAQ35239271-4BF27358-9BA5-4DD3-8825-8A4552F039E4Q35498598-59C8F485-A8CE-4E07-97C5-11D4CF3B29DFQ36251731-BE6EBF04-54AE-47FD-A60A-AD94E0B4AE5AQ36960001-D26279FD-585B-4DA2-885F-08C046402681Q37487079-6DC97C90-CCD1-431C-85F0-D81999A57127Q37743207-C4F52B9E-0A9B-47A1-BE8A-C20BC2685D42Q38306561-025D1BEE-DF31-4800-8E19-9B48741AF363Q38780081-E5347341-E494-4531-8AA2-C863C6717262Q38873953-70F357B6-9D49-423C-B0AD-208463D33745Q38890219-D48EEEC5-29C9-4F4E-A244-F32551A7FD68Q39440973-CEB0A0AB-D55A-474F-A54C-8B7B529A1005Q41087142-7E5FD895-061F-4543-889F-54D24EDACC88Q42099455-E9FBDD56-1CAC-493C-8621-562A7FC81BFDQ42660472-AFD7D98B-BA47-4B15-B529-3EA721F7E7ADQ50863945-2AB8DF97-14EA-4FF8-BAE4-7DE13356F149Q51011636-ECC83DA1-A00C-43D2-828A-BE56F92A5D6EQ53124532-5BC18636-B938-41BC-9BA4-A6CE712CF5B7Q53589389-6D659459-9144-4B0A-96F7-1CFD94D6846DQ55086681-CD2E3D22-AB1F-4822-9A39-F14C0BF57C58Q58795206-F1950856-567A-4466-9FFB-BCED1116A55B
P2860
Platelet factor 4: production, structure, and physiologic and immunologic action.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Platelet factor 4: production, structure, and physiologic and immunologic action.
@ast
Platelet factor 4: production, structure, and physiologic and immunologic action.
@en
type
label
Platelet factor 4: production, structure, and physiologic and immunologic action.
@ast
Platelet factor 4: production, structure, and physiologic and immunologic action.
@en
prefLabel
Platelet factor 4: production, structure, and physiologic and immunologic action.
@ast
Platelet factor 4: production, structure, and physiologic and immunologic action.
@en
P1476
Platelet factor 4: production, structure, and physiologic and immunologic action.
@en
P2093
P304
P356
10.3181/00379727-198-43309
P577
1991-11-01T00:00:00Z